James Love, Vice President of Automation and Process Optimisation at Novo Nordisk, discusses how automation can help drive efficiencies in labs and how the company has worked alongside Standardization in Lab Automation (SiLA) to improve processes. As a large pharmaceutical company, responsible for around 60,000 employees worldwide and well-known for supplying almost 50% of the […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!